The ASEAN CBD gummies market will grow from an estimated USD 1.2 billion in 2025 to USD 5.3 billion by 2035, reflecting a CAGR of 16% during the forecast period from 2025 to 2035.
| Attributes | Value |
|---|---|
| Estimated ASEAN Industry Size (2025) | USD 1.2 billion |
| Projected ASEAN Value (2035) | USD 5.3 billion |
| Value-based CAGR (2025 to 2035) | 16% |
Regulatory changes, growing CBD health benefit awareness, and escalating demand for functional wellbeing products will propel the ASEAN market's growth. Thailand, Malaysia, and Singapore have relaxed CBD product regulations, and licensed retailers are permitted to sell gummies as part of the wellness industry. The growth in the demand for traditional herbal medicine combined with contemporary CBD forms will also hasten market growth. The industry will grow 4.4X between 2025 and 2035, driving an absolute dollar opportunity of USD 4 billion.
Explore FMI!
Book a free demo
A comparative analysis of CAGR changes between 2024 and 2025 provides insights into shifting market trends and revenue growth.
CAGR Trends in the ASEAN CBD Gummies Market (2024 to 2025)
The ASEAN CBD gummies market will grow at a CAGR of 13.2% in the first half of 2024, rising to 14.7% in the second half. In 2025, the market will expand further, reaching 15.1% in H1 and 16.5% in H2. This growth reflects increasing government approvals, greater investment in CBD production, and higher consumer interest in alternative health solutions.
| Date | Development & Details |
|---|---|
| March 2024 | Thailand introduced CBD-infused gummies in registered wellness clinics, allowing local producers to expand sales. |
| June 2024 | Malaysia’s Ministry of Health approved a pilot project for CBD gummies in pharmacies, making them available under prescription. |
| September 2024 | Singapore eased regulations, permitting CBD-infused functional edibles for medical use, leading to a rise in pharmaceutical partnerships. |
| November 2024 | Indonesia allowed the import of CBD gummies for research purposes, opening discussions for potential retail legalization. |
Consumers Prefer CBD Gummies for Holistic Wellness
ASEAN consumers increasingly turn to CBD gummies for holistic wellness due to their convenience, precise dosing, and integration with traditional herbal remedies. Unlike CBD oils, which require careful measurement and often have a bitter aftertaste, gummies provide a discreet, pre-measured, and flavorful alternative. In Thailand, Kannika Botanicals has successfully blended broad-spectrum CBD with local herbs like turmeric and lemongrass, offering consumers a familiar yet modern approach to wellness.
Many ASEAN consumers seek natural solutions for stress relief, sleep enhancement, and pain management, aligning with long-standing cultural preferences for plant-based healing. In Malaysia, NutriWell Malaysia has introduced CBD-infused gummies with ashwagandha, a well-known adaptogen in traditional medicine. These gummies appeal to working professionals dealing with high stress and anxiety.
Regulatory progress has also enhanced consumer confidence in CBD gummies. CBD is approved by Thailand and Malaysia for wellness purposes and is being sold in pharmacies and wellness centers. GreenLab Malaysia, one of the best-known CBD brands, partners with authorized pharmacies to supply doctor-approved CBD gummies for anxiety and muscle recovery, bolstering confidence in consumers who opt for medical endorsement for wellness products.
Retail and e-commerce have enabled CBD gummies to be more widely available throughout ASEAN. Websites such as CBD Asia Direct provide personalized subscription plans where consumers can select formulations that are appropriate for sleep aid, immunity enhancement, or relaxation. Meanwhile, Singapore-based MediCBD is leading the way in low-THC, prescription-strength CBD gummies to cater to health-oriented consumers who value strict local regulations.
Increasing regulatory approval, cultural acceptance of herbal supplements, and technological advancements in CBD products have led ASEAN consumers to increasingly adopt CBD gummies as a reputable and holistic approach to well-being. The union of natural compounds, simplicity of consumption, and therapeutic potential makes CBD gummies a mainstream wellness product within the region.
Regulatory Reforms Will Strengthen Market Growth
Regulatory reforms in ASEAN are fueling growth in the CBD gummies market by enhancing consumer confidence, refining product quality levels, and enhancing retail availability. Thailand, Malaysia, and Singapore are making moves to create regulated frameworks that facilitate controlled sales of CBD-infused edibles.
Thailand takes the lead in the regulatory shift by allowing CBD products, such as gummies, for medical and wellness use. The Thai FDA has certified local brands such as Kannika Botanicals to market CBD gummies in authorized wellness clinics, enabling consumers to purchase lab-tested products with proper dosage instructions. This has stimulated local farmers and producers to venture into hemp cultivation, driving the entire supply chain.
Malaysia is slowly embracing a more formalized strategy. GreenLab Malaysia's pilot venture to sell CBD gummies through approved pharmacies was approved by the Malaysian Ministry of Health in 2024. By demanding strict adherence to Good Manufacturing Practices (GMP), Malaysia provides assurance that only high-quality, clinically vetted CBD gummies are made available to consumers. This regulatory change has encouraged wellness brands to create formulations to relieve stress, manage pain, and promote sleep.
Singapore is still being cautious but has started to approve CBD-infused edibles for medicinal purposes. MediCBD Singapore has just gained approval to distribute prescription-grade, THC-free CBD gummies to patients suffering from chronic pain and anxiety. This policy change has prompted pharmaceutical companies to invest in research and development, hoping that CBD edibles will be more widely legalized in the near term.
These regulatory developments are broadening distribution channels. Internet sites such as CBD Asia Direct now provide government-approved CBD gummies with open labeling, which builds consumer confidence. With more ASEAN nations streamlining their policies, the market for CBD gummies will see strong growth, fueled by greater accessibility, standardized quality, and growing acceptance of plant-based wellness solutions.
Thailand leads the ASEAN CBD gummies market based on liberal cannabis laws, a robust wellness tourism sector, and well-developed herbal medication culture. Thailand became Southeast Asia's first country to legalize hemp-based CBD, permitting licensed enterprises to produce and sell CBD-enriched products, including gummies. This regulatory win has placed Thailand ahead in the sector in the region.
The Thai FDA has played an active role in promoting the growth of CBD products by issuing licenses to local brands such as Kannika Botanicals and SiamCBD. These firms have launched CBD gummies containing popular Thai herbs like turmeric, lemongrass, and pandan, reflecting consumers' interest in natural and holistic wellness products. This blending of CBD with locally trusted ingredients has provided Thai brands with a distinctive advantage over regional competitors in other ASEAN nations.
Thailand's thriving wellness tourism sector also drives market expansion. Tourist hubs such as Bangkok, Chiang Mai, and Phuket now boast CBD wellness retreats, spas, and herbal medicine clinics that include CBD-infused gummies in their products. Visiting foreigners who want relaxation and pain relief drive sales, making Thailand an essential CBD market for domestic and international consumers.
The government's support for domestic hemp cultivation has tightened the supply chain. Thai farming cooperatives have collaborated with CBD producers to provide quality hemp cultivation, less dependence on imports, and a lower cost of CBD gummies for consumers. Retail growth has also been an important contributor, with top health shops, pharmacies, and online websites such as CBD Thailand Direct providing multiple CBD gummies with laboratory-tested compositions.
With its regulatory leadership, incorporation of traditional herbs, and booming wellness tourism industry, Thailand remains at the forefront of ASEAN's CBD gummies market, laying the groundwork for sustained industry growth in the region.
Malaysia is set for explosive growth in the CBD gummies market since government-supported regulation enables pharmacy-verified CBD products to penetrate the mainstream wellness market. The Malaysian Ministry of Health has recently granted pilot programs for the sale of CBD-infused gummies via licensed pharmacies to ensure product safety and medical authenticity.
GreenLab Malaysia was the first business approved for distributing CBD gummies in pharmacies, specifically with products formulated for anxiety relief, pain relief, and insomnia improvement. By consulting closely with medical practitioners, GreenLab makes sure its products adhere to Good Manufacturing Practices (GMP) and that the CBD concentrations are labeled clearly. Such medical endorsement is boosting consumer confidence and bringing in health-conscious shoppers who prefer regulated, doctor-backed CBD products over non-verified options.
Pharmacies such as Guardian and Caring Pharmacy have started selling CBD gummies based on firm regulatory guidelines, providing a safe and legal shopping route. In contrast with Thailand, where CBD is relatively common in stores for wellness, Malaysia takes a more pharmacy-based approach to sales, which upholds its emphasis on quality control. Its well-regulated distribution framework will appeal considerably to middle-income professionals and older consumers seeking science-grounded CBD products.
Malaysia's steady regulatory transition is also drawing investment by pharmaceutical firms and well-being brands. NutriWell Malaysia has formulated CBD gummies blended with ashwagandha and chamomile, targeting stress management and relaxation. The firm has collaborated with major pharmacies to make controlled distribution possible, as CBD gummies can now be a trusted means for people looking for holistic health.
As regulations change, more health and pharmaceutical brands will come into Malaysia's CBD market, fueling retail growth and making it more accessible. With a government-initiated emphasis on pharmacy-approved products, Malaysia will be one of the ASEAN region's fastest-growing CBD gummies markets.
Full-spectrum CBD gummies dominate the ASEAN market because they align with traditional plant-based healing practices and offer enhanced therapeutic benefits. Consumers in Thailand and Malaysia prefer these gummies for stress relief, pain management, and sleep support due to their synergy of cannabinoids and terpenes. Brands like Kannika Botanicals and GreenLab Malaysia lead the market by infusing CBD with local herbs like turmeric and lemongrass, appealing to wellness-conscious buyers. With Thailand’s legalization of hemp-derived CBD and Malaysia’s approval of pharmacy-sold CBD gummies, full-spectrum formulations continue to thrive as the preferred choice for natural and effective wellness solutions.
E-commerce will continue to be the most sought-after channel for selling CBD gummies in ASEAN due to its greater accessibility, competitive pricing, and convenience of discreet purchase. Thai and Malaysian consumers like online stores such as CBD Asia Direct, which sell certified full-spectrum and broad-spectrum gummies with comprehensive lab reports. Regulatory compliance in Thailand has enabled cross-border shipping, thereby increasing market reach. GreenLab Malaysia was able to successfully execute subscription-based online selling, providing convenience for repeat customers. With rising regulatory transparency and a surging uptake of digital, consumers remain to prefer e-commerce due to its convenience, transparency, and variety of products, making it the prevailing retail channel in ASEAN.
The ASEAN CBD gummies market is still fairly fragmented, with a combination of well-established wellness brands, pharmaceutical firms, and new startups vying for market share. Key players like Kannika Botanicals, GreenLab Malaysia, MediCBD Singapore, SiamCBD, and NutriWell Malaysia are dominating the market by emphasizing regulatory compliance, conventional herbal formulations, and pharmacy-backed distribution.
Kannika Botanicals leads Thailand's CBD gummies market by blending broad-spectrum CBD with regionally respected herbs such as turmeric, lemongrass, and pandan. Kannika has secured a solid position in wellness centers and health shops throughout Bangkok and Chiang Mai, appealing to both local consumers and global wellness travelers. Kannika's capacity to blend conventional Thai herbal medicine with contemporary CBD products has provided it with a distinct market position.
GreenLab Malaysia has emerged as a leader in pharmacy-approved CBD gummies. Being the first company to gain Malaysian government approval for the distribution of CBD, GreenLab collaborates closely with healthcare providers to provide doctor-recommended formulations. By distributing CBD gummies to Guardian and Caring Pharmacy, the company has established a high standard of quality control and consumer confidence in Malaysia's nascent market.
MediCBD Singapore has made a market niche in prescription-grade, THC-free CBD gummies aimed at chronic pain and anxiety sufferers. As Singapore permits CBD only for medicinal purposes, MediCBD works with pharmaceutical companies and hospitals to supply strictly controlled products. It has established scientific trial credibility, which may put it in pole position for market growth if Singapore relaxes CBD regulations someday.
SiamCBD, another large Thai player, has extended its reach by distributing full-spectrum CBD gummies in wellness resorts and traditional herbal medicine stores. NutriWell Malaysia, meanwhile, has created functional CBD gummies with ashwagandha and chamomile, targeting consumers looking for stress relief and relaxation. As regulations keep changing, competition in ASEAN's CBD gummies market will become fiercer, fueling innovation and wider market access.
| Company | Market Position |
|---|---|
| Kannika Botanicals (Thailand) | Leading full-spectrum CBD gummy brand in Thailand |
| GreenLab Malaysia | First company to receive approval for pharmacy-distributed CBD gummies |
| MediCBD Singapore | Specializes in THC-free, pharmaceutical-grade CBD gummies |
| SiamCBD (Thailand) | Integrates Thai herbal medicine with CBD-infused edibles |
| NutriWell Malaysia | Focuses on doctor-recommended CBD gummies for anxiety relief |
The ASEAN CBD gummies market will grow at a CAGR of 16% from 2025 to 2035.
The market will reach USD 5.3 billion by 2035.
Growth will be fueled by regulatory approvals, demand for alternative wellness products, and increased online availability.
Thailand will lead, followed by Malaysia and Singapore.
Leading brands include Kannika Botanicals, GreenLab Malaysia, MediCBD Singapore, SiamCBD, and NutriWell Malaysia.
Curcumin Market Insights - Health Benefits & Industry Expansion 2025 to 2035
Microalgae in Fertilizers Market - Growth & Sustainability Trends 2025 to 2035
Dairy Enzymes Market Trends - Innovations & Demand 2025 to 2035
Dinner Ready-to-Eat (RTE) Food Market - Trends & Consumer Insights 2025 to 2035
Potato Flakes Market Analysis Snack Foods, Ready Meals, Food Service, Bakery, Soups & Sauces, Others End Use Application Through 2035
A detailed analysis of the Australian Vitamin Premix industry and growth outlook covering vitamin type, form, and end user segment
ASEAN CBD Gummies Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
